-
Italy, Britain suggest age limits for AstraZeneca vaccine but still recommend it
Italy recommended that AstraZeneca’s Covid-19 shot only be used on those over 60 and Britain that people under 30 should get an alternative, due to possible links between the vaccine and very rare cases of blood clots.
-
Singapore to accept Covid-19 digital travel pass from next month
Singapore will next month accept visitors who use a mobile travel pass containing digital certificates for Covid-19 tests and vaccines, its aviation regulator said on Monday, becoming one of the first countries to adopt the initiative.
-
Miscarriage tied to increased mortality
Miscarriage is associated with increased premature mortality in mothers, suggests an observational study in The BMJ.
-
Mistakes even healthy people make
There are some mistakes that even the most health concerned people can also commit without knowing. Let us have a look at some of these and try to avoid as much as possible.
-
How does living with children affect adults’ risk for COVID-19 and its outcomes?
During the second wave in England, SARS-CoV-2 infection and related hospital admission (but not ICU admission or death) were slightly elevated among younger adults who lived with children.
-
World TB Day 2021: The clock is ticking
More than a century has passed since the March 24, 1882, announcement by Robert Koch that Mycobacterium tuberculosis (Mtb) bacteria cause
-
WHO report says animals likely source of Covid-19
A joint WHO-China study on the origins of Covid-19 says that transmission of the virus from bats to humans through another animal is the most likely scenario and that a lab leak is “extremely unlikely,” according to a draft copy obtained by The Associated Press.
-
Data withheld from WHO team probing Covid-19 origins in China: Tedros
Data was withheld from World Health Organization investigators who travelled to China to research the origins of the coronavirus epidemic, WHO Director-General Tedros Adhanom Ghebreyesus said.
-
Japanese health minister apologises for staff breaking Covid-19 protocols
Japan’s health minister has apologised after media reported ministry employees had gathered at a restaurant late at night in Tokyo in violation of the government’s Covid-19 contagion protocols.
-
Lead poisoning and stunting in Bangladesh: a missing link
Long-term malnutrition might at first seem like a medical condition and its remedial measures easy, using balanced diet, appropriate for age, along
-
Mental health aftermath of COVID-19: long-hauler depression?
Recent surveys during the COVID-19 pandemic have documented substantial rates of depression, anxiety, and overall distress in as many as one-third
-
COVID-19 reinfection uncommon, but older adults seem at higher risk
The risk for reinfection with SARS-CoV-2 is generally low, but it is higher among adults aged 65 and older, according to a population-based study from Denmark published in The Lancet.
-
Very low risk of getting COVID-19 from food and packaging
The risk of getting COVID-19 from food you cook yourself or from handling and consuming food from restaurants and takeout or drive-thru meals is thought to be very low. Currently, there is no evidence that food is associated with spreading the virus that causes COVID-19.
-
Draft regulations on trans fatty acids opened for public consultation
In order to safeguard public health, the draft regulations on “Limiting Trans Fatty Acid in Food Products Regulations, 2021” has been uploaded for public consultation on the website of Bangladesh Food Safety Authority.
-
Colorectal cancer: Mass awareness is the key
Advertisements for haemorrhoids, fistula and treatments for these diseases are a common sight glued on walls and pillars on our way back and forth home.
-
Vitamin D deficiency during COVID-19: a paediatric perspective
Vitamin D deficiency is one of the most prevalent micronutrient deficiencies in the world. It has emerged as a public health problem in many developing countries of the world including Bangladesh.
-
COVID-19 vaccines: AstraZeneca issued statement on blood clots
AstraZeneca issued a statement recently to reassure the public about the safety of its COVID-19 vaccine after several European Union (EU) countries halted its use over concerns about blood clots.
-
Amyloid-targeted treatment seems to slow progression of Alzheimer’s
Donanemab is associated with a modest slowing of Alzheimer disease progression in patients with early symptomatic disease, according to an industry-conducted phase 2 trial published in the New England Journal of Medicine and presented at the International Conference on Alzheimer’s and Parkinson’s Disease.
-
New statistical model predicts which cities could become “super-spreaders”
Researchers have developed a new statistical model that predicts which cities are more likely to become infectious disease hotspots, based both on interconnectivity between cities and the idea that some cities are more suitable environments for infection than others.
-
Covid-19: Healthcare disruptions may have caused 228,000 child deaths in South Asia, says Unicef
A new UN report titled Direct and Indirect Effects of Covid-19 Pandemic and Response in South Asia claims that healthcare disruptions caused by Covid-19 may have led to an estimated 228,000 child deaths in South Asia.
-
Germany, France among nations to resume use of AstraZeneca vaccine
Germany, France and other European nations have announced plans to resume using AstraZeneca’s Covid-19 vaccine after EU and British regulators moved to shore up confidence in the shot, saying its benefits outweigh the risks.
-
We want to be self-sufficient in vaccine production: health minister
Bangladesh is already self-sufficient in food and medicine production, and now wants to be self-sufficient in vaccine production as well, said Health Minister Zahid Maleque this evening during a visit to the vaccine plant of Incepta Pharmaceuticals Ltd at Jirabo area of Ashulia in Savar.
-
Virus variants found to be deadlier, more contagious; some may thwart vaccines
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.
-
The dangerous new variant of Coronavirus
COVID-19, which is caused by SARS-CoV-2, has snatched countless lives over the past one year. The pandemic is still in headway from the beginning of 2020 to present.
-
France, Italy call EU medicines regulator’s comments on AstraZeneca vaccine ‘encouraging’
Comments by the European Medicines Agency (EMA) on the AstraZeneca vaccine are “encouraging”, French President Emmanuel Macron and Italian Prime Minister Mario Draghi said.
-
Should you take vaccine if you are COVID-19 affected?
As there is no specific treatment so far to overcome the deadly disease of COVID-19, sufferers are only managed symptomatically and supportive. So how we can get rid of this disease?
-
Surgery should be delayed for at least seven weeks following a COVID-19 diagnosis
New international research published in Anaesthesia (a journal of the Association of Anaesthetists) concludes that surgery should be delayed for seven weeks after a patient tests positive for SARS-CoV-2, since the data show that surgery that takes place between 0 and 6 weeks after diagnosis is associated with increased mortality.
-
Devastatingly pervasive: 1 in 3 women globally experience violence
Violence against women remains devastatingly pervasive and starts alarmingly young, shows new data from the World Health Organisation (WHO) and partners. Across their lifetime,
-
Colorectal cancer screening is suggested for persons aged 45–49 years
The American College of Gastroenterology (ACG) now suggests that colorectal cancer screening begin as early as age 45 in average-risk individuals. Previously, the ACG recommended screening this early only for African Americans.
-
Hong Kong scientist develops retinal scan technology to identify early childhood autism
A Hong Kong scientist has developed a method to use machine learning and artificial intelligence to scan retinas of children as young as six to detect early autism or the risk of autism and hopes to develop a commercial product this year.
ADVERTISEMENT
